Neurocrine Biosciences
NBIX
#1689
Rank
NZ$21.59 B
Marketcap
NZ$215.15
Share price
-1.13%
Change (1 day)
2.52%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company